Three-in-one parenteral nutrition in neonates and pediatric patients: Risks and benefits

Nutrition in Clinical Practice

Volumn 30, Issue 3, 2015, Pages 337-343

  Blackmer, Allison Beck ^a   Partipilo, M Luisa ^b,c  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

home parenteral nutrition; neonates; newborn infant; parenteral nutrition; parenteral nutrition solutions; pediatrics

Indexed keywords

AMINO ACID; ELECTROLYTE; GLUCOSE; LIPID EMULSION; MINERAL; VITAMIN; TRACE ELEMENT;

BACTERIUM CONTAMINATION; CATHETER OCCLUSION; CENTRAL VENOUS CATHETER; CHILD; DRUG COST; DRUG FORMULATION; DRUG INCOMPATIBILITY; DRUG STABILITY; HUMAN; INTRAHEPATIC CHOLESTASIS; LIVER DISEASE; NEWBORN; PARENTERAL NUTRITION; PRECIPITATION; REVIEW; RISK BENEFIT ANALYSIS; CHEMISTRY; ECONOMICS; PEDIATRICS; PROCEDURES; RISK ASSESSMENT;

AMINO ACIDS; CHILD; ELECTROLYTES; FAT EMULSIONS, INTRAVENOUS; GLUCOSE; HUMANS; INFANT, NEWBORN; PARENTERAL NUTRITION; PEDIATRICS; RISK ASSESSMENT; TRACE ELEMENTS; VITAMINS;

EID: 84930340024     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533615580596     Document Type: Review

References (64)

1. Engle WA. Age terminology during the perinatal period. Pediatrics. 2004 ; 114: 1362-1364
2. Solassol C, Joyeux H. New techniques for long-term parenteral nutrition. Ann Surg. 1974 ; 179 (4). 519-522
3. Solassol C, Joyeux H, Etco L, Pujol H, Romieu C. New techniques for long-term intravenous feeding: an artificial gut in 75 patients. Ann Surg. 1974 ; 179: 519-522
4. Solassol C, Joyeux H, Yakoun M, Pujol H, Romieu C. New technics for chronic parenteral feeding [in French]. Ann Chir. 1974 ; 28: 785-794
5. Warshawsky KY. Intravenous fat emulsions in clinical practice. Nutr Clin Pract. 1992 ; 7: 187-196
6. Sayeed FA, Tripp MG, Sukumaran KB, Mikrut BA, Stelmach HA, Raihle JA. Stability of various total nutrient admixture formulations using Liposyn II and Aminosyn II. Am J Hosp Pharm. 1987 ; 44: 2280-2286
7. Uppsala, Sweden: Fresenius Kabi ; 2014 :
8. U.S. Food and Drug Administration.Kabiven and Perikabiven NDA 200656 approval letter. http://www.accessdata.fda.gov/drugsatfda-docs/appletter/2014/200656Orig1s000ltr.pdf. Accessed December 27, 2014.
9. Rollins CJ. Total nutrient admixtures: stability issues and their impact on nursing practice. J Intraven Nurs. 1997 ; 20: 299-304
10. Boullata JI, Gilbert K, Sacks G, et al. A.S.P.E. N. clinical guidelines: parenteral nutrition ordering, order review, compounding, labeling, and dispensing. JPEN J Parenter Enteral Nutr. 2014 ; 38: 334-377
11. Hardy G, Puzovic M. Formulation, stability, and administration of parenteral nutrition with new lipid emulsions. Nutr Clin Pract. 2009 ; 24: 616-625
12. Mirtallo J, Canada T, Johnson D, et al. Safe practices for parenteral nutrition. JPEN J Parenter Enteral Nutr. 2004 ; 28: S39 - S70
13. Driscoll DF. Physicochemical assessment of total nutrient admixture stability and safety: quantifying the risk. Nutrition. 1997 ; 13: 166-167
14. United States Pharmacopeia 31/National Formulary 26. Rockville, MD: United States Pharmacopeial Convention ; 2008: 285-287.
15. Driscoll DF. Total nutrient admixtures: theory and practice. Nutr Clin Pract. 1995 ; 10: 114-119
16. Driscoll DF, Bhargava HN, Li L, Zaim RH, Babayan VK, Bistrian BR. Physicochemical stability of total nutrient admixtures. Am J Health Syst Pharm. 1995 ; 52: 623-634
17. Driscoll DF, Thoma A, Franke R, Klutsch K, Nehne J, Bistrian BR. Lipid globule size in total nutrient admixtures prepared in three-chamber plastic bags. Am J Health Syst Pharm. 2009 ; 66: 649-656
18. Tucker A, Ybarra J, Bingham A, et al. American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) standards of practice for nutrition support pharmacists. Nutr Clin Pract. 2015 ; 30 (1). 139-146
19. Driscoll DF, Nehne J, Peterss H, Klutsch K, Bistrian BR, Niemann W. Physicochemical stability of intravenous lipid emulsions as all-in-one admixtures intended for the very young. Clin Nutr. 2003 ; 22: 489-495
20. Ribeiro Dde O, Lobo BW, Volpato NM, da Veiga VF, Cabral LM, de Sousa VP. Influence of the calcium concentration in the presence of organic phosphorus on the physicochemical compatibility and stability of all-in-one admixtures for neonatal use. Nutrition. 2009 ; 8: 51
21. Kerner JA, Poole RL. The use of IV fat in neonates. Nutr Clin Pract. 2006 ; 21: 374-380
22. Wales PW, Allen N, Worthington P, et al. A.S.P.E.N. clinical guidelines: support of pediatric patients with intestinal failure at risk of parenteral nutrition-associated liver disease. JPEN J Parenter Enteral Nutr. 2014 ; 38: 538-557
23. Rollins MD, Ward RM, Jackson WD, et al. Effect of decreased parenteral soybean lipid emulsion on hepatic function in infants at risk for parenteral nutrition-associated liver disease: a pilot study. J Pediatr Surg. 2013 ; 48: 1348-1356
24. Colomb V, Jobert-Giraud A, Lacaille F, Goulet O, Fournet JC, Ricour C. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enteral Nutr. 2000 ; 24: 345-350
25. Rollins MD, Scaife ER, Jackson WD, Meyers RL, Mulroy CW, Book LS. Elimination of soybean lipid emulsion in parenteral nutrition and supplementation with enteral fish oil improve cholestasis in infants with short bowel syndrome. Nutr Clin Pract. 2010 ; 25: 199-204
26. Cober MP, Killu G, Brattain A, Welch KB, Kunisaki SM, Teitelbaum DH. Intravenous fat emulsions reduction for patients with parenteral nutrition-associated liver disease. J Pediatr. 2012 ; 160: 421-427
27. Gura KM, Lee S, Valim C, et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics. 2008 ; 121: e678 - e686
28. de Meijer VE, Gura KM, Le HD, Meisel JA, Puder M. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience. JPEN J Parenter Enteral Nutr. 2009 ; 33: 541-547
29. de Meijer VE, Gura KM, Meisel JA, Le HD, Puder M. Parenteral fish oil as monotherapy for patients with parenteral nutrition-associated liver disease. Pediatr Surg Int. 2009 ; 25: 123-124
30. Lee SI, Valim C, Johnston P, et al. Impact of fish oil-based lipid emulsion on serum triglyceride, bilirubin, and albumin levels in children with parenteral nutrition-associated liver disease. Pediatr Res. 2009 ; 66: 698-703
31. Puder M, Valim C, Meisel JA, et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg. 2009 ; 250: 395-402
32. Goulet O, Antebi H, Wolf C, et al. A new intravenous fat emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil: a single-center, double-blind randomized study on efficacy and safety in pediatric patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr. 2010 ; 34: 485-495
33. Sanchez SE, Braun LP, Mercer LD, Sherrill M, Stevens J, Javid PJ. The effect of lipid restriction on the prevention of parenteral nutrition-associated cholestasis in surgical infants. J Pediatr Surg. 2013 ; 48: 573-578
34. Durfee SM, Adams SC, Arthur E, et al. A.S.P.E.N. standards for nutrition support: home and alternate site care. Nutr Clin Pract. 2014 ; 29: 542-555
35. Driscoll DF, Silvestri AP, Bistrian BR. Stability of MCT/LCT-based total nutrient admixtures for neonatal use over 30 hours at room temperature: applying pharmacopeial standards. JPEN J Parenter Enteral Nutr. 2010 ; 34: 305-312
36. O'Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. 2011 ; 39: S1-34
37. Walshe CM, Boner KS, Bourke J, Hone R, Phelan D. Diagnosis of catheter-related bloodstream infection in a total parenteral nutrition population: inclusion of sepsis defervescence after removal of culture-positive central venous catheter. J Hosp Infect. 2010 ; 76: 119-123
38. Pontes-Arruda A, Dos Santos MC, Martins LF, et al. Influence of parenteral nutrition delivery system on the development of bloodstream infections in critically ill patients: an international, multicenter, prospective, open-label, controlled study - EPICOS study. JPEN J Parenter Enteral Nutr. 2012 ; 36: 574-586
39. Gerlach AT, Thomas S, Murphy CV, et al. Does delaying early intravenous fat emulsion during parenteral nutrition reduce infections during critical illness?. Surg Infect (Larchmt). 2011 ; 12: 43-7
40. Yilmaz G, Koksal I, Aydin K, Caylan R, Sucu N, Aksoy F. Risk factors of catheter-related bloodstream infections in parenteral nutrition catheterization. JPEN J Parenter Enteral Nutr. 2007 ; 31: 284-287
41. Dissanaike S, Shelton M, Warner K, O'Keefe GE. The risk for bloodstream infections is associated with increased parenteral caloric intake in patients receiving parenteral nutrition. Crit Care. 2007 ; 11: R114
42. Chheng ML, Heidbreder C, Btaiche IF, Blackmer AB. Infectious complications with nondaily versus daily infusion of intravenous fat emulsions in non-critically ill adults. Nutr Clin Pract. 2013 ; 28: 737-744
43. Mirtallo JM, Dasta JF, Kleinschmidt KC, Varon J. State of the art review: intravenous fat emulsions: current applications, safety profile, and clinical implications. Ann Pharmacother. 2010 ; 44: 688-700
44. Melly MA, Meng HC, Schaffner W. Microbiol growth in lipid emulsions used in parenteral nutrition. Arch Surg. 1975 ; 110: 1479-1481
45. Gilbert M, Gallagher SC, Eads M, Elmore MF. Microbial growth patterns in a total parenteral nutrition formulation containing lipid emulsion. JPEN J Parenter Enteral Nutr. 1986 ; 10: 494-497
46. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol. 2002 ; 23: 759-769
47. Vasilakis A, Apelgren KN. Answering the fat emulsion contamination question: three in one admixture vs conventional total parenteral nutrition in a clinical setting. JPEN J Parenter Enteral Nutr. 1988 ; 12: 356-359
48. Turpin RS, Solem C, Pontes-Arruda A, et al. The impact of parenteral nutrition preparation on bloodstream infection risk and costs. Eur J Clin Nutr. 2014 ; 68: 953-958
49. Kovacevich DS, Frederick A, Kelly D, et al. Standards for specialized nutrition support: home care patients. Nutr Clin Pract. 2005 ; 20: 579-590
50. Kitchen P, Forbes A. Intravenous nutrition: focus on delivery (3-in-1 bags or not?). Curr Opin Gastroenterol. 2000 ; 16: 184-187
51. Uslu S, Ozdemir H, Comert S, Bolat F, Nuhoglu A. The effect of low-dose heparin on maintaining peripherally inserted percutaneous central venous catheters in neonates. J Perinatol. 2010 ; 30: 794-799
52. Tang J, Li XH, Wang H, Xiong Y, Mu DZ. Administration of low-dose heparin in total nutrient admixture prevents central venous catheter-related infections in neonates [in Chinese]. Zhongguo Dang Dai Er Ke Za Zhi. 2009 ; 11: 983-985
53. Lim MS, Choi CW, Kim BI, Yang HR. Clinical factors affecting lipid metabolism and optimal dose of heparin in preterm infants on parenteral nutrition. Pediatr Gastroenterol Hepatol Nutr. 2013 ; 16: 116-122
54. Birch P, Ogden S, Hewson M. A randomised, controlled trial of heparin in total parenteral nutrition to prevent sepsis associated with neonatal long lines: the Heparin in Long Line Total Parenteral Nutrition (HILLTOP) trial. Arch Dis Child Fetal Neonatal Ed. 2010 ; 95: F252 - F257
55. Moclair A, Bates I. The efficacy of heparin in maintaining peripheral infusions in neonates. Eur J Pediatr. 1995 ; 154: 567-570
56. Silvers KM, Darlow BA, Winterbourn CC. Pharmacologic levels of heparin do not destabilize neonatal parenteral nutrition. JPEN J Parenter Enteral Nutr. 1998 ; 22: 311-314
57. Trissel LA, Gilbert DL, Martinez JF, Baker MB, Walter WV, Mirtallo JM. Compatibility of medications with 3-in-1 parenteral nutrition admixtures. JPEN J Parenter Enteral Nutr. 1999 ; 23: 67-74
58. Ryan DM, Daniels CE, Somani SM. Personnel costs and preparation time in a centralized intravenous admixture program. Am J Hosp Pharm. 1986 ; 43: 1222-1225
59. Eskew JA. Fiscal impact of a total nutrient admixture program at a pediatric hospital. Am J Hosp Pharm. 1987 ; 44: 111-114
60. Rollins CJ, Elsberry VA, Pollack KA, Pollack PF, Udall JN. Three-in-one parenteral nutrition: a safe and economical method of nutritional support for infants. JPEN J Parenter Enteral Nutr. 1990 ; 14: 290-294
61. Erdman SH, McElwee CL, Kramer JM, Zuppan CW, White JJ, Grill BB. Central line occlusion with three-in-one nutrition admixtures administered at home. JPEN J Parenter Enteral Nutr. 1994 ; 18: 177-181
62. American Society for Parenteral and Enteral Nutrition. Recommendations for parenteral nutrition intravenous fat emulsions product shortage considerations. May2013. http://www.nutritioncare.org/Guidelines-and-Clinical-Practice/Clinical-Practice-Library/Parenteral-Nutrition-Intravenous-Fat-Emulsions-Product-Shortage-Considerations. Accessed December 30, 2014.
63. Deerfield, IL: Baxter Healthcare Corporation ; 2006 :
64. Pediatric Nutrition Support Core Curriculum. Corkins M, ed. Silver Springs, MD: American Society for Parenteral and Enteral Nutrition ; 2010 :